Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ136013610,00
KB100910130,60
PKN144,28144,3-0,01
Msft505,6506,7-0,23
Nokia7,617,62-0,86
IBM248,89249,98-1,30
Mercedes-Benz Group AG40,9540,965-0,47
PFE30,92310,88
03.11.2026 11:52:54
Indexy online
AD Index online
select
AD Index online
 

  • 23.10.2026 13:55:03
OTP Bank (Praha)
Poslední obchod Změna (%) Změna (CZK) Objem obchodů (CZK)
2 695,00 0,00 0,00 0
R - Real-Time data z pražské burzy ZDARMA pro registrované uživatele Přihlásit.
Z - Zavřená fáze, O - Otevřená fáze, A - Aukce, V - Volatility break, P - Pozastaveno

 
  • Poslední aktualizace: 03.11.2026
Popis společnosti

Business Summary: OTP Bank Nyrt is a Hungary-based commercial bank. The Bank’s operations are structured into three business segments: Retail, Corporate and Private banking. The Retail banking segment is involved in account management, bankcards and electronic services through telephone, mobile phone and Internet. The Corporate banking segment offers account-keeping services, financing, investments and electronic services for medium-sized and large companies. The private banking segment offers Hungarian Forint and foreign currencies account management, investment and fund management and loan facilities. The Bank’s specialized services, including car leasing, investment funds and insurance are developed and offered by the Bank's subsidiaries, including OTP Fund Management Ltd, DSK Asset Management (Bulgaria), OTP Travel Ltd, OTP Life Annuity Plc., OTP Mortgage Bank and OTP Factoring Ltd, among others.
Financial Summary: BRIEF: For the six months ended 30 June 2026, OTP Bank Nyrt interest income increased 10% to HUF1.809T. Net interest income after loan loss provision increased 16% to HUF989.08B. Net income before extraordinary items decreased 7% to HUF480.06B. Net interest income after loan loss provision reflects OTP Core Hungary segment increase of 20% to HUF359.56B, Russia segment increase of 63% to HUF135.39B, Net Interest Margin.



  • Poslední aktualizace: 03.11.2026
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
Chief Executive Officer, Member of the Executive Committee, DirectorBelen Garijo6501.05.2026
Executive Vice President, Chief People Officer - ad interim, Member of the Executive CommitteeVeronique Jaillet-01.09.202601.09.2026
Executive Vice President - Finance, Member of the Executive CommitteeFrancois-Xavier Roger6401.09.202601.04.2024
Executive Vice President, General Counsel, Member of the Executive CommitteeJamie Haney-01.09.202601.09.2026
Executive Vice President - Specialty Care, Member of the Executive CommitteeManuela Buxo-01.03.202601.03.2026
Executive Vice President, Head - Research & Development, Member of the Executive CommitteePaulo Fontoura-01.09.202601.09.2026
Executive Vice President - General Medicines, Member of the Executive CommitteeThomas Grenier-01.09.202601.09.2026
Executive Vice President - Manufacturing & Supply, Member of the Executive CommitteeBrendan O'Callaghan6501.09.202601.10.2021
Executive Vice President - Vaccines, Member of the Executive CommitteeThomas Triomphe5115.06.2020